ArticlePloS one2023

Understanding the medication experience of patients with advanced non-small cell lung cancer taking epidermal growth factor receptor-tyrosine kinase inhibitors: A phenomenological study.

Meng-Jung Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.